Clinical efficacy and safety evaluation of bevacizumab combined with conventional chemotherapy in the treatment of advanced ovarian cancer

doi:10.3969/j.issn.1672-3384.2022.09.012

WANG Hui-ping, DONG Xiao-liang

Clinical Medication Journal ›› 2022, Vol. 20 ›› Issue (9) : 62-66.

PDF(410 KB)

Clinical Medication Journal ›› 2022, Vol. 20 ›› Issue (9) : 62-66. DOI: 10.3969/j.issn.1672-3384.2022.09.012

Original Article

Clinical efficacy and safety evaluation of bevacizumab combined with conventional chemotherapy in the treatment of advanced ovarian cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 20(9): 62-66 https://doi.org/10.3969/j.issn.1672-3384.2022.09.012

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(410 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2022-04-06	2022-09-28
Issue Date
2022-09-28

Please choose a citation manager

Content to export